Havana, April 8 (Prensa Latina) Cuba has recorded a new achievement with the health registration granted to NeuroEpo, an innovative medicine to delay the progression of mild to moderate Alzheimer’s disease and improve the life of people suffering from that condition.
The April issue of The Havana Reporter remembers the Playa Giron feat 62 years after the United States’ first military defeat in Latin America. Other topics covered by this edition are the preparations for the 2022 International Tourism Fair in May, after having been postponed two years due to COVID-19, the continuing solidarity with Cuba […]
Havana, Mar 9 (Prensa Latina) The President of Cuba, Miguel Díaz-Canel, today praised the approval by the national regulatory entity of the conditional health registry of the NeuroEpo molecule for mild and moderate Alzheimer's.